Cardiac Output, Low Clinical Trial
Official title:
Myocardial Protection With Perhexiline in Left Ventricular Hypertrophy
Open-heart surgery causes injury of the heart muscle. Although this is usually mild,
temporary and reversible, if it is severe it can endanger life and require additional high
cost care. During surgery, techniques are used to protect the heart from injury, but these
remain imperfect. Patients with a thickened wall of the heart (left ventricular hypertrophy)
may be at greater risk. This study assesses the effect of facilitating sugar metabolism (a
more efficient fuel) by the heart muscle using the drug Perhexiline given before the
operation.
This treatment has a sound experimental basis for improving outcome. If this improvement is
confirmed surgical results could be improved. The investigators will be studying heart
function, heart muscle energy stores and chemicals which quantify the amount of heart muscle
injury. The investigators' hypothesis is that Perhexiline will improve the protection of the
heart by decreasing damage that may occur during heart surgery.
n/a
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05070819 -
Atrial Natriuretic Peptide in Assessing Fluid Status
|
N/A | |
Recruiting |
NCT05492968 -
The Effect of Epinephrine, Norepinephrine and Phenylephrine on Intraoperative Hemodynamic Performance
|
Phase 4 | |
Completed |
NCT03444545 -
Continous Cardiac Output - Non-Invasive Evaluation (CONNIE)
|
||
Recruiting |
NCT04064177 -
Non-invasive Continuous Cardiac Output Monitoring in Preterm Infants Study
|
||
Withdrawn |
NCT03058653 -
Use of a Mini-fluid Bolus to Identify Fluid Responsiveness
|
N/A | |
Completed |
NCT02880683 -
Cardiac Output Autonomic Stimulation Therapy for Heart Failure (COAST-HF) - Human NeuroCatheter Study
|
N/A | |
Completed |
NCT04955184 -
Comparing Cardiac Output Measurements Using a Wearable, Wireless, Non-invasive PPG-Based Device to a Swan Ganz Catheter
|
||
Completed |
NCT02964663 -
Comparison of the Ability of the esCCO and the Volume View to Measure Trends in Cardiac Output During Cardiac Surgery
|
N/A | |
Completed |
NCT04641949 -
Methoxyflurane and Fentanyl in LBNP
|
Phase 4 | |
Recruiting |
NCT04191408 -
Predictive Ability of PEEP Induced Changes in CVP to Predict Volume Responsiveness in Mechanically Ventilated Patients After Major Abdominal Surgery
|
N/A | |
Completed |
NCT01892696 -
Effects of Inspiratory Flow Waveforms on Preload
|
N/A | |
Recruiting |
NCT02728791 -
Comparison of Allows Measurement of Cardiac Output Between Clearsight System and Transpulmonary Thermodilution
|
N/A | |
Completed |
NCT03930979 -
The Effect of Hyperoxia on Cardiac Output
|
||
Recruiting |
NCT04755764 -
Effect of Labetalol, Atenolol, and Nifedipine on Maternal Hemodynamics Measured by ICG in Early Pregnancy
|
||
Enrolling by invitation |
NCT02702544 -
Effect of Passive Leg Raising for Fluid Responsiveness
|
N/A | |
Completed |
NCT01880684 -
Validation of Capnography as a Predictor of Cardiac Output Change as Measured by FloTrac
|
Phase 2 | |
Recruiting |
NCT05035719 -
Comparison Studies Comparing Hemodynamic Parameters Provided by the Caretaker Against Respective Gold Standard References
|
||
Not yet recruiting |
NCT04774978 -
Real-time Continuous Cardiac Output Measurements
|
N/A | |
Completed |
NCT02485782 -
Changes in Volumetric Hemodynamic Parameters Induced by Fluid Removal on Hemodialysis
|
N/A | |
Completed |
NCT00446017 -
The Effects of Adrenaline and Milrinone in Patients With Myocardial Dysfunction After CABG
|
Phase 3 |